Cipla to invest upto 100 million pounds in UK as part of expansion.

Pharma major Ciplawill invest up to 100 million pounds (nearly Rs. 1,030 crore) in UK over next few years for launch and development of new drugs as part of its global footprint expansion plans.

The company will provide high quality affordable medicines to British National Health Service ( NHS).

'I am happy to be able to announce that Indian pharmaceutical company Cipla will invest up to GBP 100 million in the UK,' a company statement said quoting UK Chancellor of the Exchequer George Osborne.

He further added the investment will fund the launch of a range of drugs in the areas of respiratory, oncology and antiretroviral segments.

This will include research and development, clinical trials and further expansion internationally and in the UK.


ET